Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VRTX is expected to report earnings to fall 131.64% to $4.06 per share on October 30

Vertex Pharmaceuticals VRTX Stock Earnings Reports

Q3'24

Est.

$4.06

Q2'24

Missed

by $1.13

Q1'24

Beat

by $0.68

Q4'23

Beat

by $0.13

Q3'23

Beat

by $0.05

The last earnings report on August 01 showed earnings per share of -1282 cents, missing the estimate of -1169 cents. With 733.71K shares outstanding, the current market capitalization sits at 122.53B.

View a ticker or compare two or three

Compare

VRTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VRTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VRTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

50 Northern Avenue

Phone

+1 617 341-6100

Employees

5400

Web

https://www.vrtx.com